title: Phase 3 data for PCSK9 inhibitor wows.
authors: Cormac
authors: C
authors: Sheridan
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D006937:Hypercholesterolemia / Q000175:diagnosis* / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors*; D012697:Serine Endopeptidases; D016896:Treatment Outcome
chemical_list: D000960:Hypolipidemic Agents; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases